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 and 
 
in vitro
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SUMMARY
 
Experimental leishmaniasis is widely used to study the effector
functions of  T helper cell subsets 
 
in vivo
 
. Healing and
nonhealing 
 
Leishmania major
 
 infections have been correlated
with T helper 1 and T helper 2 responses, respectively. In the
present study, we determined T cell effector functions 
 
ex vivo
 
,
without any further restimulation and compared them to those
obtained following antigen-specific restimulation 
 
in vitro
 
. Our
results show that T helper cell responses are significantly
less polarized when determined 
 
ex vivo
 
 as compared to those
measured after restimulation 
 
in vitro
 
. Moreover, the differences
in CD4
 
+
 
 T cell proliferation observed between healer and
nonhealer strains of mice differed 
 
ex vivo
 
 and 
 
in vitro
 
. Our
results suggest that determination of both 
 
ex vivo
 
 as well as
 
in vitro
 
 T cell responses is crucial to characterize immune
responses during experimental leishmaniasis.
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INTRODUCTION
 
The leishmaniases are a group of  vector-borne parasitic
diseases that inflict an immense toll in the developing world;
they are major causes of morbidity and mortality and impede
economic development. Currently, these diseases affect an
estimated 12 million people in 88 countries, and approximately
350 million people are at risk. The leishmaniases belong
to the most neglected tropical diseases, affecting the poorest
populations, for whom access to diagnosis and effective treat-
ment are most difficult (http://www.who.int/leishmaniasis/en/).
Leishmaniases present with a wide range of symptoms, ranging
from the self healing cutaneous form, which produces localized
skin ulcers; to the mucocutaneous form, which leads to the
destruction of mucous membranes of the mouth, throat,
nose and neighbouring tissue; to the visceral form, the most
severe form of leishmaniasis, in which the mortality rate can
be as high at 100%. A multitude of factors, including parasite
and vector species, host immune responses, genetic and environ-
mental factors influence the outcome of infection.
T lymphocytes are central players in the host response of
all forms of leishmaniasis; they are decisive for both healing
and the generation of  protective immunity as well as for
nonhealing persistent disease and pathology. Experimental
studies in inbred strains of mice with 
 
Leishmania (L.) major
 
mimic the healing and nonhealing manifestation of leishma-
niasis and have established the current paradigm of T helper
(Th) cell subset involvement (1–3). In this model, the majority
of  inbred strains of  mice develop small lesions that will
spontaneously heal within a few weeks; this ability to control
infection is associated with the expansion of  Th1 cells,
characterized by the production of IFN-
 
γ
 
. In contrast, a few
strains of mice such as BALB/c develop nonhealing disease,
attributed to the expansion of Th2 cells and the production
of their signature cytokines interleukin (IL)-4 and IL-13.
 
Leishmania
 
 are obligate intracellular parasites in their
mammalian host. After transmission into their host, they invade
and parasitize mainly macrophages, which are decisive effector
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cells that either kill or host the intracellular parasites depending
on the balance between Th1 and Th2 cytokines: Th1 cytokines
induce classical activation of  macrophages and inducible
nitric oxide synthase (iNOS) that oxidizes 
 
l
 
-arginine into
nitric oxide (NO), a metabolite responsible for the killing of
intracellular 
 
Leishmania
 
 parasites (4). Th2 cytokines result
in alternative activation of macrophages and the induction
of arginase (5), which metabolizes 
 
l
 
-arginine into urea and
ornithine; the latter is the main intracellular source for the
synthesis of polyamines necessary for parasite growth (6,7).
In addition to the canonical type 1 and type 2 T helper cell
responses, IL-10, a cytokine originally described as a type 2
cytokine (8), plays an important role in leishmaniasis. Both
CD4
 
+
 
CD25
 
+
 
FoxP3
 
+
 
 T cells (9) and CD4
 
+
 
CD25
 
–
 
FoxP3
 
–
 
 Th1
cells (10) have been shown to express IL-10 and play a crucial
role in parasite persistence and in immunosuppression.
In the experimental model of leishmaniasis, the type of
immune responses that is associated with healing or
nonhealing has been largely defined by measuring cytokine
production following 
 
in vitro
 
 restimulation of lymphoid cells
with 
 
Leishmania
 
 parasites. However, these do not necessarily
reflect immune responses in the infected host 
 
in vivo
 
. There-
fore, to assess immune responses induced in response to infec-
tion with 
 
L. major in vivo
 
, we measured CD4
 
+
 
 T cell effector
functions directly 
 
ex vivo
 
, in freshly isolated cells from the
lymph nodes draining the cutaneous lesions and compared
them to recall responses obtained after 
 
in vitro
 
 restimulation.
 
MATERIALS AND METHODS
 
Mice
 
Female BALB/c and CBA mice (6- to 8-week old) (Charles River,
UK) were kept in individually vented cages. Animal colonies,
screened regularly for mouse pathogens, consistently tested
negative. Animal experiments were performed in accordance
with Governmental (Home Office) and Institutional Guidelines.
 
Experimental infection with 
 
L. major
 
 parasites
 
For infections, 2 
 
× 
 
10
 
6
 
 stationary phase 
 
L. major
 
 LV39 (MRHO/
SU/59/P-strain) promastigotes were injected subcutaneously
(s.c.) into the footpad (11).
 
Proliferation assay
 
Preparation of cells
Ex vivo
 
: 
 
L. major
 
 infected mice were treated with 1 mg 5-bromo-
2-deoxyuridine (BrdU, Sigma) i.p. once a day for the last 4 days
before experiments were terminated. Draining lymph nodes from
individual mice were homogenized into single cell suspensions
using cell dissociation sieves and labelled as described below.
 
In vitro
 
: Popliteal lymph nodes from 2 or 4 week infected
nonhealer (BALB/c) and healer (CBA) strains of mice were
homogenized and 5 
 
×
 
 10
 
6
 
/mL cells were restimulated for 5 days
with 1 
 
×
 
 10
 
6
 
 live 
 
L. major
 
 parasites or 1 
 
×
 
 10
 
6
 
 crude 
 
L. major
 
antigen (frozen and thawed three times) in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 5%
foetal bovine serum (FBS), 50 IU/mL penicillin, 50 mg/mL
streptomycin and 292 mg/mL 
 
l
 
-glutamine (Gibco). BrdU was
added to the cell culture 18 h before the cells were harvested
and labelled as described below.
Before surface labelling with anti-CD4 mAb (clone H129·19
or GK1·5, Pharmingen), cells were preincubated with 1 
 
μ
 
g
of rat anti-mouse monoclonal antibody CD32/CD16 (Fc
 
γ
 
II/
III receptor, Pharmingen). Cells were washed, fixed and
permeabilized using the method described in (12). Detection
of CD4
 
+
 
 BrdU
 
+
 
 cells was performed using a FACSCalibur
(BD) and data were analysed using Summit v4·3 software.
Isotype control: 0·57%.
 
Intracellular cytokine determination
 
Preparation of cells
Ex vivo
 
: Individual draining lymph nodes were harvested from
2 week infected mice and were homogenized into single cell
suspensions using cell dissociation sieves.
 
In vitro
 
: Lymph node cells were stimulated with 
 
L. major
 
parasites as described above and harvested after 5 days.
Cells (1 
 
×
 
 10
 
6
 
) were stimulated with 50 ng of  phorbol
12-myristate 13-acetate (PMA; Sigma) and 500 ng of ionomycin
(Calbiochem) or, as a control, in the presence of  complete
medium alone for 4 h, with 10 
 
μ
 
g of Brefeldin A (Sigma) added
for the last 2 h. Before surface labelling with anti-CD4 mAb (clone
H129·19 or GK1·5, Pharmingen), cells were preincubated with
1 
 
μ
 
g of rat antimouse monoclonal antibody CD32/CD16
(Fc
 
γ
 
II/III receptor, Pharmingen). Cells were washed, fixed and
permeabilized as described in (13) before the anti-cytokine
antibodies or the isotype controls were added [anti-IL-4 mAb,
clone BVD4–1D11; anti-IFN-
 
γ
 
 mAb, clone XMG1·2; anti-IL-
10 mAb, clone JES5–16E3; appropriately labelled rat immu-
noglobulin (Pharmingen)]. Detection of intracellular cytokines
was performed using a FACSCalibur (Becton–Dickinson) and
data were analysed using Summit v4·3 software.
Isotype control for IFN-
 
γ
 
: 0·27 ± 0·04%, IL-4: 0·25 ± 0·05%
and IL-10: 0·22 ± 0·05%, respectively. All cytokines were
below the detection limit when the cells were stimulated in
the absence of PMA/ionomycin stimulation. The detection
limits were defined as percentage isotype control +3 standard
deviations: IFN-
 
γ
 
 = 0·39%, IL-4 = 0·40% and IL-10 = 0·37%.
iMFI: The integrated mean fluorescent intensity (iMFI)
(14) was obtained by multiplying the percentage of CD4
 
+
 
 T
cells with the value of the mean fluorescent intensity (MFI) for
BrdU or with the value of the MFI for the relevant cytokine.
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Luminex
 
Lymphocytes were stimulated as described above and 3 days
later, supernatants were harvested and IFN-
 
γ
 
 and IL-4 were
detected simultaneously in each sample by the Luminex-based
Multiplexed assay (Luminex 100 System). Data were analysed
using STarstation V2·0.
 
Statistical analyses
 
Statistical differences were determined using a two-tailed Mann–
Whitney test and differences were considered statistically
significant at 
 
P
 
 < 0·05.
 
RESULTS
 
Production of the cytokines IFN-γ
 
, IL-4 and IL-10 is 
strongly amplified after restimulation
 
In the experimental model of leishmaniasis, immune responses
have mostly been characterized by restimulating lymphoid
cells from infected mice with 
 
Leishmania 
 
antigen 
 
in vitro
 
(1,2). To determine how closely these responses reflect the
host response to 
 
Leishmania
 
 infection, we compared CD4
 
+
 
T cell responses from 
 
L. major
 
 infected mice 
 
ex vivo
 
 and 
 
in vitro
 
.
We infected nonhealer mice (BALB/c) and healer mice (CBA)
with 
 
L. major
 
 promastigotes and measured 2 weeks later
CD4
 
+
 
 T cell effector functions directly 
 
ex vivo
 
 in the draining
lymph nodes and compared them with those obtained after
 
in vitro
 
 restimulation with 
 
L. major
 
 parasites as antigen. We
first assessed the production of  the type-1 cytokine IFN-
 
γ
 
in 
 
L. major
 
 infected healer and nonhealer strains directly
 
ex vivo
 
, without 
 
in vitro
 
 restimulation. As shown in Figure 1A,
the frequency of CD4
 
+
 
IFN-
 
γ
 
+
 
 T cells was lower in the lymph
nodes from BALB/c mice as compared to CBA mice (1·8 ± 0·1%
vs. 2·1 ± 0·2%, 
 
P
 
 < 0·05, Figure 1A,B). A recent study has
described a new metric parameter, the integrated mean fluores-
cence intensity (iMFI), which reflects more precisely the total
functional response of activated T cells (14). iMFI is calcu-
lated by multiplying the percentage of  positive cells, which
represents the magnitude of the response by the MFI, which
represents the quality of the response. As shown in Figure 1,
the CD4
 
+
 
IFN-
 
γ
 
+
 
 iMFI was lower in BALB/c than in CBA
mice when determined directly 
 
ex vivo 
 
(30·6 ± 2·6 vs. 52·8 ± 3·4,
 
P
 
 < 0·05). Similar results were obtained when the frequency,
MFI and iMFI of CD4
 
+
 
IFN-
 
γ
 
+
 
 T cell were determined directly
 
ex vivo
 
 4 weeks post 
 
L. major
 
 infection (
 
P < 
 
0·05, Table 1A).
Next we restimulated lymph node cells from 2 week infected
mice with 
 
L. major
 
 parasites for 5 days (15) and measured the
percentages, MFI and iMFI of CD4
 
+
 
IFN-
 
γ
 
+
 
. As shown in
Figure 1C, after 
 
in vitro
 
 restimulation these three parameters
were considerably higher in the lymph node cultures from
CBA mice as compared to those of BALB/c mice (
 
P < 
 
0·05).
Similar results were obtained when we measured IFN-
 
γ
 
levels in the supernatants of restimulated lymph node cells
(23·1 ± 2·7 pg/mL vs. 10·9 ± 0·9 pg/mL, 
 
P
 
 < 0·05, Figure 1D).
Moreover, a comparable increase in percentage, MFI and
iMFI of CD4
 
+
 
IFN-
 
γ
 
+
 
 T cells was observed when lymphoid
cells from 4 weeks infected mice were restimulated with
 
L. major
 
 parasites in vitro (P < 0·05, Table 1B).
The higher production of IFN-γ observed in vitro with cells
from CBA mice (Figure 1C,D) was not due a higher number
of  cells after restimulation, as the total number of  cells
after in vitro restimulation was even higher in the BALB/c
mice (15·0 × 105 ± 0·8 × 105 cells/mL (BALB/c cultures) vs.
8·9 × 105 ± 0·6 × 105 cells/mL (CBA cultures), data not shown).
Table 1 Percentage, MFI and iMFI of CD4+IFN-γ+ T cells
(A)
(B)
Ex vivo Percentage of CD4+IFN-γ+ (%) MFI CD4+IFN-γ+ iMFI CD4+IFN-γ+
BALB/c 1·1 ± 0·2 22·3 ± 2·1 25·0 ± 2·4
CBA 1·6 ± 0·3 23·4 ± 1·9 36·5 ± 2·9
In vitro Percentage of CD4+IFN-γ+ (%) MFI CD4+IFN-γ + iMFI CD4+IFN-γ+
BALB/c 13·2 ± 1·2 225·0 ± 21·0  2970 ± 32·9
CBA 30·3 ± 2·8 398·0 ± 20·9 12059·4 ± 98·7
Groups of BALB/c and CBA (n = 4) mice were infected with L. major parasites in one hind footpad. Four weeks later, individual popliteal 
lymph nodes were harvested and the percentage of IFN-γ-expressing CD4+ T cells was determined by flow cytometry:
(A) Ex vivo: Percentage, MFI and iMFI of CD4+IFN-γ+ T cells.
(B) In vitro: Lymph node cells were restimulated with L. major parasites and 5 days later, the percentage of IFN-γ-expressing CD4+ T cells 
was determined by flow cytometry.
Data are ±SD and show the results of one representative experiment out of three independent experiments.
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Figure 1 Ex vivo and in vitro expression of IFN-γ by CD4+ T cells. Groups of BALB/c and CBA (n = 4) mice were infected with Leishmania 
major parasites in one hind footpad. Two weeks later, individual popliteal lymph nodes were harvested and the percentage of IFN-γ-expressing 
CD4+ T cells was determined directly by flow cytometry: (A) Ex vivo: Dot plot profiles of CD4+IFN-γ+ T cells; (B) %, MFI and iMFI 
of CD4+IFN-γ+ T cells. (C) In vitro: Lymph node cells were restimulated with L. major parasites and 5 days later, the percentage of 
IFN-γ-expressing CD4+ T cells was determined by flow cytometry. The error bars represent SD. (D) Lymph node cells were restimulated with 
L. major parasites and 3 days later, the supernatants were harvested and the cytokine content was determined by Luminex. The error bars 
represent standard deviations. Data show the results of one representative experiment out of five independent experiments.
© 2009 The Authors 203
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The results presented in Figure 1 show that by restimulating
lymph node cells in vitro, the differences in percentage, MFI
and iMFI of CD4+IFN-γ+ T cells between BALB/c and CBA
are amplified as compared to ex vivo.
Next, we measured the ex vivo and in vitro production of
IL-4 by CD4+ T cells in draining lymph nodes of BALB/c and
CBA mice two weeks post infection. Production of IL-4 was
higher in the BALB/c as compared to CBA mice (% CD4+IL-4+:
1·8 fold increase, MFI CD4+IL-4+: 1·1 fold increase, iMFI
CD4+IL-4+: 2·0 fold increase, Figure 2A). Comparable results
were obtained ex vivo 4 weeks post infection (P < 0·05,
Table 2A). Similarly to the tendency observed by analysing
Figure 2 Ex vivo and in vitro expression of IL-4 by CD4+ T cells. Groups of BALB/c and CBA (n = 4) mice were infected with Leishmania 
major parasites in one hind footpad. Two weeks later, individual popliteal lymph nodes were harvested and the percentage of IL-4-expressing 
CD4+ T cells was determined directly by flow cytometry: (A) Ex vivo: Dot plot profiles of CD4+IL-4+ T cell and percentage, MFI and iMFI 
of CD4+IL-4 T cells. (B) In vitro: Lymph node cells were restimulated with L. major parasites and 5 days later, the percentage of IL-4-expressing 
CD4+ T cells was determined by flow cytometry. The error bars represent standard deviations. (c) Lymph node cells were restimulated with 
L. major parasites and three days later, the supernatants were harvested and the cytokine content was determined by Luminex. The error bars 
represent standard deviations. Data show the results of one representative experiment out of five independent experiments.
204 © 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd, Parasite Immunology, 31, 199–209
B.-S. Choi & P. Kropf Parasite Immunology
IFN-γ production, the differences in IL-4 production by
CD4+ T cells between nonhealer and healer mice were
considerably increased when lymph nodes cells were restimu-
lated with L. major parasites in vitro (% CD4+IL-4+: 13·2 fold
increase, MFI CD4+IL-4+: 1·6 fold increase, iMFI CD4+IL-
4+: 21·1 fold increase, Figure 2B). The IL-4 levels were also
significantly higher in the supernatants of restimulated lymph
nodes cells (2330·0 ± 75·1 pg/mL vs. 378·5 ± 16·2 pg/mL,
P < 0·05, Figure 2C). A similar tendency was observed when
lymph node cells from 4 week infected mice were restimul-
ated with L. major parasites in vitro (P < 0·05, Table 2A).
The regulatory cytokine IL-10 could not be detected directly
ex vivo as it was below detection limit both 2 and 4 weeks
post infection (detection limit: 0·37%, data not shown).
Figure 2 Continued.
Table 2 Percentage, MFI and iMFI of CD4+IL-4+ T cells
(A)
(B)
Ex vivo Percentage of CD4+IL-4+ (%) MFI CD4+IL-4+ iMFI CD4+IL-4+
BALB/c 1·3 ± 0·2 25·2 ± 2·1 31·5 ± 2·7
CBA 0·7 ± 0·1 21·9 ± 1·9 14·9 ± 1·1
In vitro Percentage of CD4+IL-4+ (%) MFI CD4+IL-4+ iMFI CD4+IL-4+
BALB/c 14·2 ± 1·2 125·0 ± 11·2 1775·0 ± 121·9
CBA 3·3 ± 0·2 82·1 ± 4·6 270·9 ± 15·6
Groups of BALB/c and CBA (n = 4) mice were infected with L. major parasites in one hind footpad. Four weeks later, individual popliteal 
lymph nodes were harvested and the percentage of IL-4-expressing CD4+ T cells was determined by flow cytometry: (A) Ex vivo: Percentage, 
MFI and iMFI of CD4+IL-4+ T cells.
(B) In vitro: Lymph node cells were restimulated with L. major parasites and 5 days later, the percentage of IL-4-expressing CD4+ T cells was 
determined by flow cytometry.
Data are ±SD and show the results of one representative experiment out of three independent experiments.
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However, following in vitro restimulation, IL-10 production
was clearly detectable and the percentage, MFI and iMFI
were all significantly increased in the lymph nodes cells from
the BALB/c mice as compared to CBA mice (Figure 3A.
P < 0·05). Similar results were obtained when lymphoid cells
from 4 week infected BALB/c and CBA mice were restimulated
with L. major parasites in vitro (P < 0·05, Table 3).
To determine how different preparations of  L. major
parasites might affect the levels of cytokine production, we
stimulated lymph node cells from two weeks infected BALB/c
mice and CBA mice with live L. major parasites or with crude
L. major antigen (freeze and thawed L. major parasites). As
shown in Table 4, the different antigenic preparation did not
affects the levels of IFN-γ, IL-4 or IL-10 produced.
Figure 3 In vitro expression of IL-10 by CD4+ T cells. Groups of BALB/c and CBA (n = 4) mice were infected with L. major parasites in 
one hind footpad. Two weeks later, individual popliteal lymph nodes were harvested and lymph node cells were restimulated with L. major 
parasites and 5 days later, percentage, MFI and iMFI of IL-10-expressing CD4+ T cells was determined by flow cytometry. The error bars 
represent standard deviations. Data show the results of one representative experiment out of five independent experiments.
Table 3 Percentage, MFI and iMFI of CD4+IL-10+
In vitro Percentage of CD4+IL-10+ (%) MFI CD4+IL-10+ iMFI CD4+IL-10+
BALB/c 14·2 ± 1·2 125·0 ± 11·2 1775·0 ± 121·9
CBA 3·3 ± 0·2 82·1 ± 4·6 270·9 ± 15·6
Groups of BALB/c and CBA (n = 4) mice were infected with L. major parasites in one hind footpad. Four weeks later, individual popliteal 
lymph nodes were harvested restimulated with L. major parasites and 5 days later, percentage, MFI and iMFI of IL-10-expressing CD4+ 
T cells was determined by flow cytometry.
Data are ±SD and show the results of one representative experiment out of three independent experiments.
Table 4 Cytokine production following in vitro restimulation with different preparations of L. major antigens
BALB/c mice iMFI CD4+IFN-γ+ iMFI CD4+IL-4+ iMFI CD4+IL-10+
Live L. major 1297·1 ± 112·0 985·6 ± 85·2 2926·0 ± 157·5
Crude L. major antigen 1189·2 ± 98·6 1023 ± 96·3 2786·3 ± 256·7
CBA mice iMFI CD4+IFN-γ+ iMFI CD4+IL-4+ iMFI CD4+IL-10+
Live L. major 8521·3 ± 612·0 125·6 ± 9·6 826·9 ± 74·2
Crude L. major antigen 9146·8 ± 529·4 142·5 ± 8·3 901·3 ± 85·7
Groups of BALB/c and CBA (n = 4) mice were infected with L. major parasites in one hind footpad. Two weeks later, individual popliteal 
lymph nodes were harvested and restimulated with live L. major parasites or crude L. major antigen preparation. Five days later, the iMFI of 
cytokine-expressing CD4+ T cells was determined by flow cytometry.
Data are ± standard deviations and show the results of one representative experiment out of two independent experiments.
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The proliferative response of CD4+ T cells from L. major 
infected healer and nonhealer strains of mice differs both 
ex vivo and in vitro.
To characterize further CD4+ T cell effector functions ex
vivo and in vitro in healer and nonhealer strains of mice, we
measured the capacity of  CD4+ T cells to proliferate. We
first measured L. major-induced proliferation of CD4+ T
cells directly ex vivo by quantifying the frequency of CD4+
T cells that had incorporated BrdU in vivo. We found that
there was a small decrease in the frequency of proliferating
CD4+ T cells in the draining lymph nodes of nonhealer mice
compared with healer mice 2 weeks post-infection (2·65 ± 0·26%
vs. 3·50 ± 0·36%, P < 0·05, Figure 4). Similar results were
obtained 4 weeks post-infection (Table 5A). In contrast, after
restimulation in vitro with L. major antigens, CD4+ T cells
from nonhealer mice proliferated more efficiently then those
of healer mice (35·1 ± 1·5% vs. 20·6 ± 2·4%, Figure 4). A similar
tendency was observed 4 weeks post-infection (P < 0·05,
Table 5B).
These results show that the ex vivo frequency of proliferating
CD4+ T cells was lower in the draining lymph nodes of
nonhealer mice than in those of  healer mice. However,
CD4+ T cells from draining lymph nodes of  nonhealer
mice displayed a more pronounced proliferative response to
restimulation with Leishmania than those from healer mice.
DISCUSSION
Infections of mice with different strains of Leishmania parasites
have proved to be very useful models to characterize the
development and regulation of immune responses during
leishmaniasis. The balance of cytokines produced by Th1 and
Th2 cells generated in response to L. major infection pro-
vides an important conceptual framework for understanding
healing vs. nonhealing forms of leishmaniasis. Healing of
infection and development of protection against leishmani-
asis crucially depends on the development of Th1 type
immunity that can instruct parasitical control mechanisms in
infected macrophages. However, the mechanisms accounting
for insufficient control of  growth and dissemination of
Leishmania parasites and resulting in persistent nonhealing
disease in infected patients are less well understood (16).
Studies with L. major parasites in particular have clearly
established the current Th1/Th2 paradigm in which con-
trol of  infection is associated with the expansion of  Th1
cells, characterized by the production of IFN-γ and the use
of gene knockout mice confirmed the important role of Th1
type responses in the control of disease (17–19). In contrast,
nonhealing disease has been attributed to the expansion of
Th2 cells, characterized by the production of IL-4 (1–3). In
Figure 4 Ex vivo and in vitro CD4+ T cells 
proliferation. Groups of BALB/c and CBA 
(n = 4) mice were infected with L. major 
parasites in one hind footpad and were treated 
with 1 mg BrdU (Sigma) i.p. once a day for 
the last 4 days before experiments were 
terminated. Individual popliteal lymph 
nodes were harvested and the percentage of 
BrdU+CD4+ T cells was determined directly 
ex vivo by flow cytometry or following 
restimulation of lymph node cells with 
L. major parasites for 5 days. The error bars 
represent standard deviations.
Table 5 % of CD4+BrdU+ T cells
(A)
(B)
Ex vivo Percentage of CD4+BrdU+ (%)
BALB/c 1·5 ± 0·2
CBA 1·9 ± 0·1
In vitro Percentage of CD4+BrdU+ (%)
BALB/c 38·5 ± 2·9
CBA 28·8 ± 4·2
Groups of BALB/c and CBA (n = 4) mice were infected with L. 
major parasites in one hind footpad and were treated with 1 mg 
BrdU (Sigma) i.p. once a day for the last 4 days before experiments 
were terminated. Individual popliteal lymph nodes were harvested 
and the percentage of BrdU+CD4+ T cells was determined directly 
ex vivo (A) by flow cytometry or following restimulation of lymph 
node cells in vitro (B) with L. major parasites for 5 days later.
Data are ±SD and show the results of one representative 
experiment out of three independent experiments.
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this context, it is important to note that Th2 cells and the
spectrum of cytokines they release is not only impacting on
the immune response, they will directly promote the growth
of the intracellular parasites by inducing arginase 1, which
catalyses the hydrolysis of l-arginine into urea and the amino
acid l-ornithine; the latter is the first building block for the
generation of polyamines which are essential for the intrac-
ellular growth of Leishmania parasites (6,7). The regulation
of immune responses against Leishmania parasites is com-
plex and Th2 dominance cannot fully explain nonhealing
(20–24); in addition, intralesional injection of IL-4 has been
shown to induce healing and immunity to reinfection (25).
IL-4 can instruct dendritic cells to produce IL-12 and promote
Th1 development and healing in BALB/c mice (26). Further-
more, it has been shown that cure can be achieved in an
IFN-γ independent manner (18,27). Moreover, in human
leishmaniasis, the different clinical outcomes do not appear
to be associated with polarized Th1- or Th2-type responses:
whereas IL-4 is higher in the plasma of patients with visceral
leishmaniasis (VL) (28,29), a number of proinflammatory
cytokines such as IL-1, IL-6, IL-12, IFN-γ and TNF-α are
also increased (30,31).
Our in vitro results, in agreement with those of  many
others [reviewed in (1–3)], substantiate this Th1/Th2 model:
we show that after in vitro restimulation, lymphoid cells
from healer mice display a strong IFN-γ response, whereas
in nonhealer mice there is predominantly an IL-4 response.
However, when Th responses were measured directly ex vivo,
without any further restimulation, we show that the dichotomy
of  Th cell responses is not as pronounced as those after
in vitro restimulation. These results suggest that the healing
or nonhealing phenotype of L. major infected mice does not
correlate with such a polarized Th1 or Th2 response when
determined ex vivo. The causes for this strong increase in the
frequencies of CD4+IFN-γ+ or CD4+IL-4+ T cells following
in vitro restimulation are unclear. We can exclude that
apoptosis was more prominent in any of the cultures, since
there was no increase in caspase+ CD4+ T cells (P. Kropf,
unpublished results). It is possible that factors such as
costimulation or antigen presentation (32) that are specifically
influenced by in vitro restimulation conditions influence this
strong preferential expansion of Th1 or Th2 cells. Further-
more, it is possible that flow cytometry is not sensitive
enough to detect CD4+ T cells that express low levels of
IL-4 and IL-10. Indeed, IL-10 was below detection limit when
determined ex vivo even though it was clearly detectable
following in vitro restimulation with L. major parasites. IL-10
mRNA has been previously measured in the draining lymph
node of healer and nonhealer mice following infection with
L. major parasites (33,34). Taken together, these results
suggest that flow cytometry might not be a technique that is
sensitive enough to measure the frequency of CD4+IL-10+ T
cells directly ex vivo without any further restimulation. The
production of IL-10 by CD4+ T cells was clearly detectable
by flow cytometry following in vitro restimulation with L. major
parasites; CD4+ T cells from nonhealer mice produce signifi-
cantly more IL-10 than those from healer strains of mice. It
is well established that IL-10 has a down-regulatory effect
on macrophages and can inhibit IFN-γ-induced macrophage
activation (35). Moreover, IL-10 synergizes with IL-4 in the
induction of  alternative activation of  macrophages and
our previous results clearly demonstrated that IL-10 and
IL-4 synergize in promoting the parasite growth via enhanced
arginase induction and polyamine synthesis (7). Recent
work indicates that failure to control leishmaniasis is not
due to a dominant Th2 or a defective Th1 response per se
but could be ascribed to a concomitant production of IL-10
(36). Moreover, experimental evidence showed that IL-10
deficient BALB/c mice as well as inhibition of  binding of
IL-10 to its receptor improved the control of L. major infec-
tion in nonhealer strains of mice (37,38). Interestingly, some
L. major isolates produce nonhealing lesions in strains of mice
such as C57BL/6 that are usually considered to be healers
and mount a Th1 response, thus, this work clearly shows
that although Th1 responses are required for healing, they
are not sufficient (24). Importantly, our in vitro results as
well as those from others underpin these results as they
show that IL-10 is strongly expressed after restimulation of
lymphoid cells from nonhealer mice as compared to healer
mice and strengthen further the role that IL-10 might have
in the pathogenesis of nonhealing leishmaniasis.
It is also important to note that the experimental model of
infection that has been used to characterize Th cell responses
does not reproduce the biology of natural infection; indeed,
factors such as the dose of parasites inoculated (39–41), the
site of infection (39,42), the presence of saliva (43) or parasite
components, such as filamentous proteophosphoglycan (40)
have been shown to greatly influence the outcome of infec-
tion. Little is known about T cell responses in mice directly
infected with sandflies and more studies in the natural
infection model are of paramount importance to fully under-
stand T cell polarization and effector functions.
To characterize further T cell effector functions, we
determined the proliferation of  CD4+ T cells ex vivo or
after restimulation in vitro: there was a higher frequency
of CD4+BrdU+ T cells in CBA mice when measured
ex vivo, however, after in vitro restimulation, the frequency of
CD4+BrdU+ T cells was significantly higher in BALB/c mice
as compared to CBA mice. It is possible that the culture
and restimulation conditions favour a higher activation of
CD4+ T cells from BALB/c mice; indeed, the frequency of
CD4+CD25+, CD4+CD40L+, CD4+OX40L+ and CD4+CD62L−
T cells were significantly higher in the cultures of BALB/c mice
as compared to CBA mice (P. Kropf, unpublished results).
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Characterization of  T helper cell responses in healer
and nonhealer strains of mice has been instrumental in our
understanding of the mechanisms resulting in healing and
nonhealing leishmaniasis. Our results suggest that determining
both ex vivo and in vitro T cell effector functions are important
to dissect and understand the development and regulation
of immune responses during experimental leishmaniasis.
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